Table 2.

Activity of C/T and IMI/REL Against all P. aeruginosa Collected From Patients in (A) ICUs and (B) Non-ICU Wards

A, ICU
		IMI/REL, No. (%)		No. of Isolates
		Susceptible	Nonsusceptible
C/T	Susceptible	629 (87.4)	48 (6.7)	677
	Nonsusceptible	25 (3.5)	18 (2.5)	43
No. of isolates		654	66	720
B, Non-ICU
		IMI/REL, No. (%)		No. of Isolates
		Susceptible	Nonsusceptible
C/T	Susceptible	836 (91.5)	46 (5.0)	882
	Nonsusceptible	19 (2.1)	13 (1.4)	32
No. of isolates		855	59	914

Abbreviations: C/T, ceftolozane/tazobactam; ICU, intensive care unit; IMI/REL, imipenem/relebactam.